Wesselhoeft R, Jensen PB, Talati A, et al. - Individuals aged 5-19 years from the Scandinavian countries were assessed for antidepressant utilization via conducting a population-based drug utilization study using publicly available data of antidepressant use from Denmark, Norway, and Sweden. From 2007 to 2017, researchers observed a marked increase in the proportion of antidepressant users in Sweden (9.3-18.0/1,000) compared with Norway (5.1-7.6/1,000) and Denmark (9.3-7.5/1,000). Observations revealed considerable variation in antidepressant use even in highly comparable healthcare systems like the Scandinavian countries’. In 2017, they observed the cumulated defined daily doses (DDD) of selective serotonin reuptake inhibitors of 5,611/1,000 inhabitants in Sweden, 2,709/1,000 in Denmark, and 1,848/1,000 in Norway. Also, an increase in the use of ‘other antidepressants’ (ATC code N06AX) was noted in Sweden with a higher DDD in 2017 (497/1,000) compared with Denmark (225/1,000) and Norway (170/1,000). In 2017, generally low use of tricyclic antidepressants was reported with DDDs ranging between 30-42 per 1,000. They observed a markedly higher and still increasing use of antidepressants among Swedish children and adolescents vs Danish and Norwegian peers.